Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123507212 | 12350721 | 2 | F | 20160503 | 20160803 | 20160510 | 20160812 | EXP | US-TEVA-657964USA | TEVA | 73.60 | YR | F | Y | 0.00000 | 20160812 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123507212 | 12350721 | 1 | PS | CLOZAPINE. | CLOZAPINE | 1 | Oral | Y | N | 39C163 | 74949 | TABLET | |||||||
| 123507212 | 12350721 | 2 | SS | CLOZAPINE. | CLOZAPINE | 1 | Oral | Y | N | 39C163 | 74949 | TABLET | |||||||
| 123507212 | 12350721 | 3 | C | BENZATROPINE | BENZTROPINE | 1 | 0 | ||||||||||||
| 123507212 | 12350721 | 4 | C | HALDOL | HALOPERIDOL | 1 | 0 | ||||||||||||
| 123507212 | 12350721 | 5 | C | TOPIRAMATE. | TOPIRAMATE | 1 | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123507212 | 12350721 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123507212 | 12350721 | Granulocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123507212 | 12350721 | 1 | 20160503 | 0 | ||
| 123507212 | 12350721 | 2 | 20160504 | 0 |